FLNA
Filana Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical analysis is poor, scoring 1/10. MACD Death Cross, Long Upper Shadow, and Inverted Hammer all signal bearish momentum, with no bullish indicators observed in the past five days. The chart suggests further downside risk.
Analysis Checks(0/3)
Long Upper Shadow
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
Inverted Hammer
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
MACD Death Cross
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-6.22%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-6.22%
Long Upper Shadow
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
MACD Death Cross
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-6.22%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-6.22%
Inverted Hammer
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-7.14%
Technical Analysis of FLNA?
- FLNA presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 39.64 and a MACD of -0.04, with the trend anchored by the 50-Day SMA at 2.04. Traders should monitor key support at 1.64 and resistance at 1.72.
